Navigation Links
International experts to explore new 'wonderdrug' at conference
Date:9/4/2013

A gas associated with the smell of rotten of eggs is now being proven to have widespread health benefits. Hydrogen Sulfide (H2S) is widely known as a poisonous and corrosive substance, but now a mounting body of evidence suggests it could be used in a wide range of treatments for some of the biggest health problems of our time. A conference hosted by the University of Exeter will bring together world-leading scientists to explore the emerging possibilities.

The conference will take place from September 8 to 11, and will discuss new research which shows that H2S can play a role in a diverse range of functions. They include reducing joint swelling, treating cancer, preeclampsia, neurodegenerative disease, cardiovascular disease and diabetes and even helping plants grow in the dark.

On Sunday September 8 Professor Hideo Kimura will give an overview in the opening plenary entitled "Physiological Function of Hydrogen Sulfide and Beyond". The talk will take place at the Forum on the University's Streatham Campus. It starts at 6pm and is free to attend.

Conference organiser Professor Matt Whiteman, of the University of Exeter Medical School, is a world-leader in research on H2S. He said: Scientists began to take a real interest in H2S when it was discovered that the body naturally produces small quantities of this seemingly dangerous substance. Since then researches from around the world have been intrigued by the potential benefits. It very much appears from the rapidly growing body of scientific and medical literature that H2S is emerging as something of a potential wonderdrug and could in fact hold the key to solving some of our most widespread health problems such as diabetes, high blood pressure, heart attacks and arthritis. The key to unlocking these benefits is using it in the right way."


'/>"/>

Contact: Louise Vennells
l.vennells@exeter.ac.uk
44-013-927-24927
University of Exeter
Source:Eurekalert

Page: 1

Related biology news :

1. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
2. International Polar Year conference: From knowledge to action
3. Large international study finds memory in adults impacted by versions of 4 genes
4. International team uncovers new genes that shape brain size, intelligence
5. Southampton researchers lead 2 international projects to help people out of poverty
6. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
7. Washington University receives $8 million to lead international childhood malnutrition effort
8. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
9. New HealthFocus® International Study Reveals Five Very Different Weight Management Consumers
10. OU scientists and international team deciper the genetic code of the tomato
11. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/25/2017)... YORK , Jan. 25, 2017 The ... Access Management (IAM) lifecycle is comprised of a ... for the purpose of maintaining digital identities and ... resources and applications. There are significant number of ... from time to time by optimizing processes and ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... David Nolte, ... Recognition Reception at Purdue Research Park of West Lafayette, Indiana. , ... of outstanding contributions to, and success with, commercializing discoveries from Purdue research. “This ...
(Date:2/23/2017)... Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies ... Marbán, Ph.D, president and chief executive officer, is scheduled to ... Cowen and Company 37th Annual Health Care Conference Tuesday, March ... 29th Annual ROTH Conference Tuesday, ... Dana Point, CA ...
(Date:2/23/2017)... , ... February 22, 2017 , ... ... photonics , have been named Fellows of the Society this year, the Fellows ... in the multidisciplinary fields of optics, photonics, and imaging as well as their ...
Breaking Biology Technology: